Table of Contents
- Myth 1: AI Rehabilitation Requires Expensive Robotic Systems Most Clinics Can't Afford
- Myth 2: Virtual Reality Is Effective as a Standalone Stroke Rehabilitation Intervention
- Myth 3: AI Tools Perform Less Well for Older Patients
- Myth 4: Gamified Exergaming Is a Low-Evidence Add-On for Motivated Patients
- Myth 5: AI Documentation Tools Solve the After-Hours Charting Problem
- Myth 6: AI Tools for Musculoskeletal Rehabilitation Are Only Relevant for Neurological Conditions
- Myth 7: AI Adoption Resistance Is About Technophobia, Not Legitimate Evidence Concerns
- The Bottom Line
- FAQs
Clinical Summary:
The Gap: Many physical therapists hold assumptions about AI rehabilitation tools that the current evidence directly contradicts — assumptions that may be limiting treatment planning, delaying adoption where evidence supports it, or creating false confidence where caution is warranted.
The Evidence: A network meta-analysis of 33 randomized controlled trials, a 2025 Cochrane review of 190 trials, and a living systematic mapping of 240 studies provide quantifiable corrections to the most common AI rehabilitation myths physical therapists encounter in practice.
The Takeaway: Evidence-based AI integration requires the same critical appraisal skills PTs already use — applied to a new category of clinical tool.
The AI rehabilitation myths physical therapists encounter most often don't come from ignorance. They come from reasonable extrapolations from limited information, vendor pitches that substitute testimonials for evidence, and a CE landscape that hasn't kept pace with how fast the research is moving.
A cross-sectional study found that 63.3% of physical therapists reported zero hands-on experience with AI applications in clinical practice. That gap creates fertile ground for myths — about what AI tools require, what they produce, and who they help. This article examines seven of the most common, corrects each with current evidence, and draws out the clinical implications for PT practice specifically.
Myth 1: AI Rehabilitation Requires Expensive Robotic Systems Most Clinics Can't Afford
This assumption conflates AI with robotics. They overlap, but AI-driven rehabilitation includes computer vision systems, wearable sensors, and software-based telerehabilitation platforms that run on consumer devices, in addition to robotic platforms. The cost range is enormous.
Computer vision technologies powered by deep learning enable contactless assessment of joint angles, posture, and movement trajectories using a standard camera or smartphone. These systems have been validated for use in telerehabilitation and home-based settings for patients who cannot access specialized facilities. The equipment requirement is a webcam.
AI-Assisted Telerehabilitation RCT
2x
Greater pain reduction with AI-assisted multimodal telerehabilitation (NRS -3.00) vs conventional video-guided telerehabilitation (-1.50). Consumer devices only.
For physical therapists in under-resourced settings or rural practices, this matters. AI-feedback motion training uses standard cameras to guide patients through exercises with real-time form correction, supervised-quality exercise without specialized hardware or continuous clinician presence.
What to do instead: Before assuming AI rehabilitation requires capital investment, identify which specific AI applications are relevant to your patient population. Computer vision-based assessment and AI-guided telerehabilitation are available at minimal cost. Evaluate based on clinical evidence, not equipment catalogs.
Myth 2: Virtual Reality Is Effective as a Standalone Stroke Rehabilitation Intervention
This is the myth that sells the most headsets. The evidence is more precise than the marketing.
The 2025 Cochrane review analyzed 190 randomized controlled trials enrolling 7,188 participants, the largest evidence synthesis in the field. When virtual reality was used as a replacement for conventional therapy, it showed only slight improvements in upper limb function and balance, both at low certainty. Not no benefit, but low certainty, slight effect.
Virtual reality added to usual care probably increases upper limb function in stroke rehabilitation — SMD of 0.42 at moderate certainty. VR replacing usual care? Only slight improvements at low certainty. The distinction is the entire clinical question.
When VR was added to usual care, the picture changed: moderate-certainty evidence for improved upper limb function (SMD 0.42), low-certainty evidence for balance improvement (SMD 0.68). A separate meta-analysis found hybrid VR combined with conventional therapy significantly improved motor function (SMD 0.44) and manual dexterity (SMD 0.33), with benefits maintained at follow-up.
Dosing matters too. Optimal parameters for upper limb VR: total dose exceeding 15 hours, sessions longer than 4 weeks, more than 4 sessions per week at approximately 1 hour each. Lower doses produce lower effects.
What to do instead: Position VR as an adjunct that amplifies what you are already doing, not a replacement for it. If you are evaluating VR equipment, ask vendors for evidence on the specific patient population and outcome domain you are targeting - pain, function, and range of motion have different evidence-based leaders.
Myth 3: AI Tools Perform Less Well for Older Patients
In conventional stroke rehabilitation, this assumption has statistical support: older age is independently associated with worse treatment response. The evidence is real.
What physical therapists rarely encounter is what happens when you put the same patients into robotic rehabilitation instead.
A secondary analysis of a multicenter RCT involving 190 stroke patients found that age was the only variable independently associated with worse response to conventional treatment (OR 0.948, p = 0.013). In the robotic rehabilitation group, none of the baseline variables, including age, were significantly associated with response. A meta-analysis of 13 RCTs confirmed a moderate effect favoring robotic therapy over conventional (SMD 0.59, p < 0.001).
In frail adults aged 65 and over, interactive VR training significantly improved lower-limb muscle strength (Hedges' g = 0.35), walking speed (g = 0.29), balance (g = 0.62), and reduced fall risk (g = -0.61, p < 0.001). Two of four participants in a community hip exoskeleton study who were initially below the 1.0 m/s fall-risk threshold increased above it after intervention.
What to do instead: Before assuming an older patient is a poor candidate for intensive AI-assisted rehabilitation, ask whether the limitation is the patient or the treatment method. Robotic and VR-based approaches may not carry the same age-related ceiling that conventional approaches do.
The researchers who found age predicted worse outcomes in conventional but not robotic stroke rehabilitation proposed that robotic therapy may remove the negative stereotype effect — algorithms don't adjust intensity based on implicit expectations about what older patients can achieve.
Product Spotlight:
AI In Rehabilitation: Evidence-Based Update
$37.97
Unlock the future of clinical practice with AI in Rehabilitation: An Evidence-Based Update, a premier continuing education course designed specifically for physical therapists, occupational therapists, and nurses. As artificial intelligence fundamentally reshapes rehabilitation medicine, this course provides you with the… read more
Myth 4: Gamified Exergaming Is a Low-Evidence Add-On for Motivated Patients
This one gets dismissed in casual conversation more than almost any AI rehabilitation finding. It's also the one with the strongest quantitative ranking in the network meta-analysis literature.
A network meta-analysis of 33 randomized controlled trials compared 13 AI-assisted strategies head-to-head. Gamified exergaming achieved a SUCRA of 99.6% for functional outcomes, a near-certain probability of being the top intervention for improving function across musculoskeletal conditions. Therapeutic exergaming ranked first for pain relief (SUCRA 87.6%).
Conventional care ranked last across all domains. Not near the bottom. Last.
MSK Network Meta-Analysis (33 RCTs)
99.6%
SUCRA for gamified exergaming for functional outcomes. Near-certain probability of being the best intervention in its category.
SUCRA (Surface Under the Cumulative Ranking curve) represents the probability that an intervention is the best option for a given outcome in network meta-analysis. A score near 100% means near-certainty of top ranking when compared against all other options simultaneously.
The clinical mechanism makes sense: gamified environments increase motivation, engagement, and adherence. Higher repetitions and sustained effort during therapy sessions are critical drivers of neuroplastic change and functional recovery. Engagement is therapeutically active, not incidental.
What to do instead: Revisit the evidence hierarchy for AI-assisted MSK interventions. The rankings differ by outcome domain: pain, function, and range of motion have different evidence-based leaders. Match the intervention to the treatment goal using the SUCRA data, not clinical intuition about what seems "serious" enough to count.
Myth 5: AI Documentation Tools Solve the After-Hours Charting Problem
The efficiency gains from AI documentation are real and worth knowing. The limitations are equally important.
A meta-analysis of 23 studies found that AI-powered documentation tools reduced documentation burden with a standardized mean difference of -0.71, a moderate effect. For highest-use clinicians (more than 80% of appointments), per-appointment time savings reached 5.8 minutes. Productivity increased an average of 5.8%.
No usage group showed statistically significant reduction in after-hours documentation time. The tool saves time during regular clinic hours. The late-night charting that most contributes to burnout persists.
Factual inaccuracies and confabulation were common across studies. Reduced performance in complex cases was consistently observed. Loss of clinical nuance was noted by clinicians reviewing AI-generated notes. Approximately 90 ambient scribe platforms currently operate with limited regulatory oversight.
What to do instead: Use AI documentation tools for efficiency gains during regular clinical hours. Treat every AI-generated note as a draft requiring active clinician review before signing - especially for patients with multiple comorbidities or atypical presentations. Advocate for institutional governance policies that include regular accuracy auditing and explicit liability allocation.
Myth 6: AI Tools for Musculoskeletal Rehabilitation Are Only Relevant for Neurological Conditions
The volume of neurological AI rehabilitation research is higher; 57.9% of studies in the systematic mapping review focused on neurological conditions. But the MSK evidence base is strong and specifically relevant to the majority of outpatient PT practice.
- AI-assisted multimodal exercise telerehabilitation for chronic low back pain: significantly greater pain reductions than conventional video-guided telerehabilitation (adjusted mean difference -1.08, p < 0.001), sustained at 8-week follow-up
- AI-based self-management apps for neck and low back pain: improved engagement and adherence through weekly personalized exercise and education recommendations
- Digital care programs supported by AI: maintained equivalent pain response rates (64% vs 63%) when the PT-to-patient ratio was increased 2.3-fold, with higher completion rates (79.9% vs 70.1%, p < 0.001)
- AI outcome prediction for orthopedic populations: 90% real-world accuracy for discharge destination prediction using random forest models
For physical therapists in outpatient orthopedic practice, the AI rehabilitation evidence is directly applicable to chronic pain, post-surgical rehabilitation, and MSK conditions — not primarily to populations they may rarely treat.
What to do instead: When evaluating AI rehabilitation literature relevance, look for the patient population and outcome domain alongside the technology type. The MSK evidence base specifically addresses the high-volume presentations in outpatient PT practice.
Myth 7: AI Adoption Resistance Is About Technophobia, Not Legitimate Evidence Concerns
This myth minimizes the profession's actual concerns and misidentifies the problem.
Qualitative research with physical therapists found that their hesitation centers on patient data privacy, potential erosion of the patient-practitioner relationship, and ethical concerns about overreliance on algorithmic decision-making. These are substantive professional concerns, not technophobia.
And the evidence base gives those concerns specific grounding: 50.8% of AI rehabilitation studies lack a comparator group. External validation has been applied in 5.8% of studies. Explainability - the ability to understand how an AI system reached its recommendation, has been incorporated in only 10.2% of studies.
Resistance to AI adoption in physical therapy isn't the problem. Uninformed resistance and uninformed adoption are both the problem. The evidence base gives clinicians the tools to distinguish which is which.
The same critical appraisal framework physical therapists apply to every other clinical tool applies here: Is it externally validated? For which population? Does it explain its recommendations? What is the comparator? These questions aren't obstacles to AI adoption - they are the professional standard for responsible AI adoption.
What to do instead: Apply the evidence-based practice framework directly to AI tool evaluation. Ask vendors for external validation data. Require explainability. Evaluate the training dataset composition against your patient population. These questions protect your patients and position your clinical judgment appropriately in the decision-making process.
The Bottom Line
The AI rehabilitation myths physical therapists encounter most often share a common root: they developed in the absence of specific evidence. The evidence now exists in systematic reviews, network meta-analyses, and randomized controlled trials that quantify what works, for whom, and under what conditions. Correcting these myths isn't about embracing AI uncritically. It's about applying the same evidence-based reasoning that defines excellent physical therapy practice to a new category of clinical tool.
For a comprehensive review of the evidence across assessment technologies, clinical effectiveness, outcome prediction, discipline-specific applications, and AI literacy, see our course: AI in Rehabilitation: Evidence-Based Update. For the foundational evidence overview that this article builds on, see AI in Rehabilitation: What the Evidence Actually Shows.
FAQs
What are the most common AI rehabilitation myths physical therapists believe?
The most common AI rehabilitation myths physical therapists encounter include the assumption that AI requires expensive robotic systems, that VR works as a standalone intervention, that AI tools perform worse for older patients, and that documentation AI eliminates after-hours charting. Current evidence from systematic reviews and RCTs directly contradicts each of these assumptions with quantifiable data.
Does the evidence support AI-assisted rehabilitation for musculoskeletal conditions or only neurological populations?
The evidence supports both. A network meta-analysis of 33 RCTs comparing 13 AI-assisted strategies found gamified exergaming ranked highest for MSK functional outcomes (SUCRA 99.6%) and therapeutic exergaming ranked highest for pain (87.6%). Significant AI rehabilitation evidence exists for chronic low back pain, orthopedic discharge prediction, and scaled caseload management.
Is there evidence that robotic rehabilitation helps older patients specifically?
Yes. A secondary analysis of 190 stroke patients found age significantly predicted worse outcomes in conventional rehabilitation but was not associated with outcomes in robotic rehabilitation. Separately, interactive VR in frail adults 65 and over significantly reduced fall risk (Hedges' g = -0.61) and improved balance, strength, and walking speed.
What are the legitimate evidence concerns about AI rehabilitation tools?
In a systematic mapping of 240 AI rehabilitation studies, 50.8% lacked a comparator group, only 5.8% included external validation, and only 10.2% incorporated explainability. These gaps are significant and justify professional caution. Responsible AI adoption requires applying the same critical appraisal standards used for any other clinical intervention.
How should physical therapists evaluate AI documentation tools?
Evidence shows AI documentation tools reduce burden (SMD -0.71) and save up to 5.8 minutes per appointment for high-frequency users, but do not significantly reduce after-hours charting and produce factual inaccuracies, especially in complex cases. Every AI-generated note requires active clinician review. Institutional governance policies and regular accuracy auditing are essential safeguards.
